Ami Fadia
Stock Analyst at Needham
(3.32)
# 998
Out of 4,944 analysts
380
Total ratings
42.77%
Success rate
3.5%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintains: Buy | $57 → $56 | $36.07 | +55.25% | 25 | Aug 7, 2025 | |
| MRUS Merus | Maintains: Buy | $97 → $96 | $67.22 | +42.81% | 30 | Aug 6, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $18 → $16 | $6.21 | +157.65% | 21 | Aug 6, 2025 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $150 | $109.39 | +37.12% | 16 | Aug 4, 2025 | |
| ALKS Alkermes | Reiterates: Buy | $45 | $28.63 | +57.18% | 3 | Jul 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $30 | $25.13 | +19.38% | 10 | Jun 26, 2025 | |
| IMRX Immuneering | Reiterates: Buy | $9 | $3.22 | +179.50% | 17 | Jun 18, 2025 | |
| COGT Cogent Biosciences | Reiterates: Hold | n/a | $11.98 | - | 23 | Jun 17, 2025 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $80 | $49.05 | +63.10% | 12 | Jun 12, 2025 | |
| BIIB Biogen | Reiterates: Hold | n/a | $135.19 | - | 41 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $202 | $117.12 | +72.47% | 32 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $17.14 | +104.20% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.56 | +221.54% | 9 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $13.77 | +37.98% | 36 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $36.67 | +33.62% | 37 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $139 | $131.62 | +5.61% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $7.35 | +294.56% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $14.90 | +2,047.65% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $24.96 | +200.54% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.82 | +2,655.33% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $23.66 | +166.27% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $5 | $4.78 | +4.60% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $17.21 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.40 | +1,471.43% | 4 | Jan 3, 2018 |
Revolution Medicines
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $56
Current: $36.07
Upside: +55.25%
Merus
Aug 6, 2025
Maintains: Buy
Price Target: $97 → $96
Current: $67.22
Upside: +42.81%
Day One Biopharmaceuticals
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $16
Current: $6.21
Upside: +157.65%
Axsome Therapeutics
Aug 4, 2025
Reiterates: Buy
Price Target: $150
Current: $109.39
Upside: +37.12%
Alkermes
Jul 29, 2025
Reiterates: Buy
Price Target: $45
Current: $28.63
Upside: +57.18%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $30
Current: $25.13
Upside: +19.38%
Immuneering
Jun 18, 2025
Reiterates: Buy
Price Target: $9
Current: $3.22
Upside: +179.50%
Cogent Biosciences
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $11.98
Upside: -
Praxis Precision Medicines
Jun 12, 2025
Reiterates: Buy
Price Target: $80
Current: $49.05
Upside: +63.10%
Biogen
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $135.19
Upside: -
Jun 11, 2025
Reiterates: Buy
Price Target: $202
Current: $117.12
Upside: +72.47%
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $17.14
Upside: +104.20%
May 13, 2025
Reiterates: Buy
Price Target: $5
Current: $1.56
Upside: +221.54%
May 8, 2025
Reiterates: Buy
Price Target: $19
Current: $13.77
Upside: +37.98%
May 7, 2025
Reiterates: Buy
Price Target: $49
Current: $36.67
Upside: +33.62%
May 6, 2025
Maintains: Buy
Price Target: $138 → $139
Current: $131.62
Upside: +5.61%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $7.35
Upside: +294.56%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $14.90
Upside: +2,047.65%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $24.96
Upside: +200.54%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.82
Upside: +2,655.33%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $23.66
Upside: +166.27%
Jan 30, 2019
Downgrades: Market Perform
Price Target: $12 → $5
Current: $4.78
Upside: +4.60%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $17.21
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.40
Upside: +1,471.43%